Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BMEA |
---|---|---|
09:32 ET | 19811 | 4.44 |
09:34 ET | 1470 | 4.4 |
09:36 ET | 1750 | 4.44 |
09:38 ET | 1940 | 4.485 |
09:39 ET | 5177 | 4.495 |
09:41 ET | 6425 | 4.4601 |
09:43 ET | 5262 | 4.5142 |
09:45 ET | 2402 | 4.5 |
09:48 ET | 1050 | 4.54 |
09:50 ET | 2453 | 4.54 |
09:52 ET | 2447 | 4.5424 |
09:54 ET | 1680 | 4.52 |
09:56 ET | 1440 | 4.5501 |
09:57 ET | 258 | 4.565 |
09:59 ET | 694 | 4.565 |
10:01 ET | 1410 | 4.55 |
10:03 ET | 230 | 4.55 |
10:06 ET | 7650 | 4.525 |
10:08 ET | 800 | 4.51 |
10:10 ET | 1598 | 4.51 |
10:12 ET | 1850 | 4.51 |
10:14 ET | 2106 | 4.485 |
10:15 ET | 100 | 4.47 |
10:17 ET | 1050 | 4.475 |
10:19 ET | 3300 | 4.48 |
10:21 ET | 1754 | 4.49 |
10:24 ET | 100 | 4.49 |
10:26 ET | 3400 | 4.53 |
10:28 ET | 500 | 4.545 |
10:30 ET | 1525 | 4.545 |
10:32 ET | 1984 | 4.54 |
10:33 ET | 225 | 4.55 |
10:35 ET | 3736 | 4.56 |
10:37 ET | 400 | 4.57 |
10:39 ET | 800 | 4.57 |
10:42 ET | 200 | 4.57 |
10:44 ET | 1718 | 4.56 |
10:46 ET | 300 | 4.56 |
10:48 ET | 3005 | 4.53 |
10:50 ET | 900 | 4.54 |
10:51 ET | 8281 | 4.535 |
10:53 ET | 100 | 4.53 |
10:55 ET | 1600 | 4.55 |
10:57 ET | 1175 | 4.55 |
11:00 ET | 3273 | 4.56 |
11:02 ET | 800 | 4.55 |
11:04 ET | 2839 | 4.53 |
11:06 ET | 1374 | 4.535 |
11:08 ET | 1518 | 4.535 |
11:09 ET | 200 | 4.52 |
11:11 ET | 200 | 4.52 |
11:13 ET | 200 | 4.535 |
11:15 ET | 1413 | 4.52 |
11:18 ET | 100 | 4.535 |
11:20 ET | 100 | 4.535 |
11:22 ET | 100 | 4.52 |
11:26 ET | 1678 | 4.535 |
11:27 ET | 4722 | 4.55 |
11:29 ET | 2102 | 4.52 |
11:31 ET | 200 | 4.51 |
11:36 ET | 100 | 4.51 |
11:38 ET | 600 | 4.5 |
11:40 ET | 649 | 4.51 |
11:42 ET | 950 | 4.51 |
11:45 ET | 200 | 4.5 |
11:47 ET | 1900 | 4.51 |
11:49 ET | 100 | 4.5 |
11:54 ET | 600 | 4.51 |
11:56 ET | 100 | 4.51 |
11:58 ET | 1777 | 4.5215 |
12:00 ET | 600 | 4.5299 |
12:02 ET | 1200 | 4.525 |
12:03 ET | 2649 | 4.54 |
12:07 ET | 5983 | 4.565 |
12:09 ET | 364 | 4.565 |
12:12 ET | 300 | 4.565 |
12:14 ET | 100 | 4.56 |
12:16 ET | 837 | 4.57 |
12:18 ET | 1344 | 4.5601 |
12:20 ET | 5195 | 4.54 |
12:21 ET | 600 | 4.54 |
12:23 ET | 200 | 4.54 |
12:25 ET | 900 | 4.558 |
12:27 ET | 200 | 4.54 |
12:30 ET | 400 | 4.5599 |
12:32 ET | 1552 | 4.54 |
12:36 ET | 3256 | 4.565 |
12:38 ET | 300 | 4.565 |
12:39 ET | 100 | 4.55 |
12:41 ET | 300 | 4.565 |
12:43 ET | 300 | 4.56 |
12:48 ET | 200 | 4.5501 |
12:50 ET | 100 | 4.55 |
12:54 ET | 545 | 4.56 |
12:56 ET | 5701 | 4.59 |
12:57 ET | 534 | 4.59 |
12:59 ET | 300 | 4.59 |
01:01 ET | 300 | 4.59 |
01:03 ET | 6759 | 4.56 |
01:06 ET | 400 | 4.56 |
01:08 ET | 4112 | 4.54 |
01:10 ET | 2300 | 4.53 |
01:12 ET | 400 | 4.53 |
01:14 ET | 932 | 4.525 |
01:15 ET | 2295 | 4.5 |
01:17 ET | 100 | 4.5 |
01:19 ET | 4387 | 4.52 |
01:21 ET | 600 | 4.52 |
01:24 ET | 2150 | 4.52 |
01:26 ET | 1004 | 4.515 |
01:28 ET | 200 | 4.515 |
01:30 ET | 2864 | 4.53 |
01:32 ET | 400 | 4.53 |
01:33 ET | 2803 | 4.52 |
01:35 ET | 606 | 4.51 |
01:37 ET | 920 | 4.52 |
01:39 ET | 300 | 4.515 |
01:42 ET | 400 | 4.51 |
01:44 ET | 400 | 4.515 |
01:46 ET | 4561 | 4.525 |
01:48 ET | 2068 | 4.515 |
01:50 ET | 1200 | 4.51 |
01:51 ET | 4523 | 4.505 |
01:53 ET | 612 | 4.5003 |
01:55 ET | 1382 | 4.505 |
01:57 ET | 300 | 4.5 |
02:00 ET | 4922 | 4.495 |
02:02 ET | 2689 | 4.455 |
02:04 ET | 11356 | 4.43 |
02:06 ET | 2349 | 4.4302 |
02:08 ET | 2060 | 4.44 |
02:09 ET | 1600 | 4.42 |
02:11 ET | 200 | 4.42 |
02:13 ET | 19622 | 4.5 |
02:15 ET | 1703 | 4.53 |
02:18 ET | 2984 | 4.54 |
02:20 ET | 1640 | 4.52 |
02:22 ET | 1400 | 4.52 |
02:24 ET | 1379 | 4.51 |
02:26 ET | 5192 | 4.525 |
02:27 ET | 200 | 4.54 |
02:29 ET | 300 | 4.53 |
02:31 ET | 700 | 4.525 |
02:33 ET | 6206 | 4.58 |
02:36 ET | 340 | 4.57 |
02:38 ET | 42004 | 4.58 |
02:40 ET | 9518 | 4.6 |
02:42 ET | 19568 | 4.6 |
02:44 ET | 550 | 4.6006 |
02:45 ET | 3696 | 4.59 |
02:47 ET | 1800 | 4.59 |
02:49 ET | 1027 | 4.59 |
02:51 ET | 8585 | 4.61 |
02:54 ET | 4943 | 4.63 |
02:56 ET | 1000 | 4.63 |
02:58 ET | 2217 | 4.62 |
03:00 ET | 1116 | 4.62 |
03:02 ET | 200 | 4.61 |
03:03 ET | 6108 | 4.605 |
03:05 ET | 1000 | 4.6 |
03:07 ET | 600 | 4.605 |
03:09 ET | 494 | 4.605 |
03:12 ET | 19624 | 4.56 |
03:14 ET | 2223 | 4.555 |
03:16 ET | 1445 | 4.55 |
03:18 ET | 2820 | 4.5401 |
03:20 ET | 5269 | 4.555 |
03:21 ET | 500 | 4.555 |
03:23 ET | 2725 | 4.535 |
03:25 ET | 10618 | 4.53 |
03:27 ET | 1771 | 4.545 |
03:30 ET | 7618 | 4.53 |
03:32 ET | 100 | 4.535 |
03:34 ET | 738 | 4.535 |
03:36 ET | 5563 | 4.525 |
03:38 ET | 7173 | 4.535 |
03:39 ET | 9587 | 4.55 |
03:41 ET | 10565 | 4.545 |
03:43 ET | 1698 | 4.545 |
03:45 ET | 1646 | 4.54 |
03:48 ET | 1615 | 4.54 |
03:50 ET | 15569 | 4.54 |
03:52 ET | 10043 | 4.52 |
03:54 ET | 22359 | 4.515 |
03:56 ET | 22340 | 4.49 |
03:57 ET | 41142 | 4.515 |
03:59 ET | 24011 | 4.53 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biomea Fusion Inc | 160.0M | -1.3x | --- |
Achieve Life Sciences Inc | 163.5M | -3.6x | --- |
Ventyx Biosciences Inc | 163.6M | -0.7x | --- |
Outlook Therapeutics Inc | 167.4M | -0.7x | --- |
X4 Pharmaceuticals Inc | 167.9M | -1.0x | --- |
Yubo International Biotech Ltd | 164.2M | -119.2x | --- |
Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of oral covalent small molecules to treat patients with metabolic diseases and genetically defined cancers. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company is utilizing its proprietary FUSION System to discover, design and develop a pipeline of covalent-binding small molecule medicines designed to maximize clinical benefit for patients. Its lead product candidate, BMF-219, is designed to be an oral, potent, and selective covalent inhibitor of menin, built from its FUSION System. It is developing BMF-219 for the treatment of menin regulated or dependent diseases, such as type 1 and type 2 diabetes as well as subtypes of liquid and solid tumors. Its second development candidate, BMF-500, a covalent inhibitor of activating mutations of the FMS-like tyrosine kinase 3 (FLT3).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $160.0M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 35.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.57 |
Book Value | $4.72 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.